Skip to content

Impact of an Exercise Program for Children Aged 4 to 6 Years With Bronchopulmonary Dysplasia

Impacte d'un Programa d'Exercici Per Nens d'Entre 4 a 6 Anys Amb Displàsia Broncopulmonar

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02523521
Enrollment
52
Registered
2015-08-14
Start date
2015-08-31
Completion date
2015-11-30
Last updated
2015-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchopulmonary Dysplasia, Healthy

Brief summary

The purpose of this study is to determine the effects of a physical activity program for children with Bronchopulmonary Dysplasia.

Detailed description

Primary objectives is: to compare exercise tolerance and aerobic capacity between healthy children with Bronchopulmonary Dysplasia children Only Bronchopulmonary Dysplasia children will realise the physical activity program. Secondary objectives are: to analyse lung function and to evaluate flexibility.

Interventions

BEHAVIORALPhysical activity program

physical activity program for a bronchopulmonary dysplasia children.

Sponsors

Hospital de Nens de Barcelona
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
4 Years to 6 Years
Healthy volunteers
Yes

Inclusion criteria

Bronchopulmonary Dysplasia Children Inclusion Criteria: * age between 4 to 6 years old * Bronchopulmonary Dysplasia diagnostic * ex-prematurity * accept to participate.

Exclusion criteria

* congenital malformations * neuromuscular disorders * gait alterations * difficulties for communication and understanding * wheezing or pulmonary disease two weeks before to start the program * hemodynamic changes (heart rate \> 130bpm, systolic blood pressure \> 130bpm, diastolic blood pressure \> 80bpm). * heart and/or lung transplantation. Healthy children Criteria: Inclusion Criteria: * age between 4 to 6 years old.

Design outcomes

Primary

MeasureTime frame
effort tolerance measured by six minute walking testsix minutes
aerobic capacity measured by shuttle run test15 minutes

Secondary

MeasureTime frame
lung function measured by spirometry5 minutes
flexibility measured by sit and reach test2 minutes

Countries

Spain

Contacts

Primary ContactNatalia Morales
natalimorales3@gmail.com+34659181232

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026